| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |